Comparative Effectiveness of Antipsychotics in Preventing Readmission for First-Admission Schizophrenia Patients in National Cohorts From 2001 to 2017 in Taiwan
Journal
Schizophrenia Bulletin
Journal Volume
48
Journal Volume
48
Journal Issue
4
Journal Issue
4
Pages
785
Start Page
785
End Page
794
ISSN
0586-7614
Date Issued
2022-06-21
Author(s)
Abstract
Antipsychotics remain the main treatment for schizophrenia, but their effectiveness is challenging to compare. We aimed to assess the comparative real-world effectiveness of antipsychotics in preventing readmission among patients in Asia with early-stage schizophrenia to inform clinical decision making.
Subjects
National Health Insurance; hospitalization; long-acting injectable antipsychotics; mental health services; risperidone
Publisher
OXFORD UNIV PRESS
Type
journal article